Trovagene (TROV +3.4%) gets a boost from positive coverage at Highline Research Advisors who,...

|By:, SA News Editor

Trovagene (TROV +3.4%) gets a boost from positive coverage at Highline Research Advisors who, through Empire Asset Management, delivers a Buy recommendation and sets a price target of $17.